JPMorgan raised the firm’s price target on Adient (ADNT) to $28 from $24 and keeps a Neutral rating on the shares. The firm upped estimates post the fiscal Q1 beat.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADNT: